163 related articles for article (PubMed ID: 8338004)
1. Inhibition of endothelium-dependent vasorelaxation by sickle erythrocytes.
Mosseri M; Bartlett-Pandite AN; Wenc K; Isner JM; Weinstein R
Am Heart J; 1993 Aug; 126(2):338-46. PubMed ID: 8338004
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of enhanced vascular smooth muscle contraction induced by sickle erythrocyte constituents.
Azubuike-Osu S; Uche OK; Ajayi IO; Ebeigbe AB
Niger J Physiol Sci; 2020 Jun; 35(1):26-32. PubMed ID: 33084615
[TBL] [Abstract][Full Text] [Related]
3. Ability of sickle cells to scavenge endothelium-derived nitric oxide is reduced.
Olmos L; Mombouli JV; Wasserstrum N; Vanhoutte PM
Acta Pharmacol Sin; 2002 Nov; 23(11):967-73. PubMed ID: 12421471
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
[TBL] [Abstract][Full Text] [Related]
5. Release of endothelium-derived relaxing factor from freshly harvested porcine endothelial cells.
Hartmann A; Saeed M; Bing RJ
Circ Res; 1987 Oct; 61(4):548-54. PubMed ID: 3498557
[TBL] [Abstract][Full Text] [Related]
6. Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.
Weir CJ; Gibson IF; Martin W
Br J Pharmacol; 1991 Jan; 102(1):162-6. PubMed ID: 1646055
[TBL] [Abstract][Full Text] [Related]
7. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity.
Mügge A; Elwell JH; Peterson TE; Harrison DG
Am J Physiol; 1991 Feb; 260(2 Pt 1):C219-25. PubMed ID: 1847583
[TBL] [Abstract][Full Text] [Related]
8. A nitric oxide-like factor mediates nonadrenergic-noncholinergic neurogenic relaxation of penile corpus cavernosum smooth muscle.
Kim N; Azadzoi KM; Goldstein I; Saenz de Tejada I
J Clin Invest; 1991 Jul; 88(1):112-8. PubMed ID: 1647413
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
[TBL] [Abstract][Full Text] [Related]
10. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture.
Phelan M; Perrine SP; Brauer M; Faller DV
J Clin Invest; 1995 Aug; 96(2):1145-51. PubMed ID: 7635951
[TBL] [Abstract][Full Text] [Related]
11. P-selectin mediates the adhesion of sickle erythrocytes to the endothelium.
Matsui NM; Borsig L; Rosen SD; Yaghmai M; Varki A; Embury SH
Blood; 2001 Sep; 98(6):1955-62. PubMed ID: 11535535
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound hemoglobin in the erythrocytes of sickle cell anemia.
Sears DA; Luthra MG
J Lab Clin Med; 1983 Nov; 102(5):694-8. PubMed ID: 6631167
[TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of fentanyl citrate on endothelium-dependent relaxation in rat aorta].
Lee K; Hatake K; Hishida S
Masui; 1994 Jan; 43(1):89-95. PubMed ID: 8309061
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-derived nitric oxide and cyclooxygenase products modulate corpus cavernosum smooth muscle tone.
Azadzoi KM; Kim N; Brown ML; Goldstein I; Cohen RA; Saenz de Tejada I
J Urol; 1992 Jan; 147(1):220-5. PubMed ID: 1370329
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment.
Hebbel RP; Eaton JW; Steinberg MH; White JG
Blood Cells; 1982; 8(1):163-73. PubMed ID: 7115974
[TBL] [Abstract][Full Text] [Related]
18. Sickle erythrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different.
Brittain HA; Eckman JR; Wick TM
J Lab Clin Med; 1992 Oct; 120(4):538-45. PubMed ID: 1402330
[TBL] [Abstract][Full Text] [Related]
19. Extracorpuscular factors in the pathogenesis of sickle cell disease.
Hebbel RP
Am J Pediatr Hematol Oncol; 1982; 4(3):316-9. PubMed ID: 7149170
[TBL] [Abstract][Full Text] [Related]
20. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
